REVIEW: Troponins and Skeletal Muscle Pathologies

---

Agnessa P. Bogomolova^1,2,a*, Ivan A. Katrukha^1,2,b

¹Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia

²Hytest Ltd., Turku, Finland

^* To whom correspondence should be addressed.

Received: May 2, 2024; Revised: November 19, 2024; Accepted: December 1, 2024

---

Skeletal muscles account for ~30-40% of the total weight of human body and are responsible for its most important functions, including movement, respiration, thermogenesis, and glucose and protein metabolism. Skeletal muscle damage negatively impacts the whole-body functioning, leading to deterioration of the quality of life and, in severe cases, death. Therefore, timely diagnosis and therapy for skeletal muscle dysfunction are important goals of modern medicine. In this review, we focused on the skeletal troponins that are proteins in the thin filaments of muscle fibers. Skeletal troponins play a key role in regulation of muscle contraction. Biochemical properties of these proteins and their use as biomarkers of skeletal muscle damage are described in this review. One of the most convenient and sensitive methods of protein biomarker measurement in biological liquids is immunochemical analysis; hence, we examined the factors that influence immunochemical detection of skeletal troponins and should be taken into account when developing diagnostic test systems. Also, we reviewed the available data on the skeletal troponin mutations that are considered to be associated with pathologies leading to the development of diseases and discussed utilization of troponins as drug targets for treatment of the skeletal muscle disorders.

---

KEY WORDS: skeletal muscle, troponin, ageing, myopathy, biomarker, monoclonal antibodies

DOI: 10.1134/S0006297924120010

Publisher’s Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

---